Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
38,823,079
-
Share change
-
+775,776
-
Total reported value
-
$290,789,367
-
Put/Call ratio
-
53%
-
Price per share
-
$7.49
-
Number of holders
-
76
-
Value change
-
+$6,187,732
-
Number of buys
-
38
-
Number of sells
-
32
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q3 2018
As of 30 Sep 2018,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,823,079 shares.
The largest 10 holders included
LEVIN CAPITAL STRATEGIES, L.P., PRIMECAP MANAGEMENT CO/CA/, Neuberger Berman Group LLC, Russell Investments Group, Ltd., BlackRock Inc., Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, ORBIMED ADVISORS LLC, STATE STREET CORP, and Endurant Capital Management LP.
This page lists
77
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.